The clinical diversity and role of chemotherapy in lymphoproliferafive disorder in liver transplant recipients

Journal of Hepatology

Volumn 27, Issue 6, 1997, Pages 1015-1021

  McCarthy, Michelle ^a   Ramage, John ^a   McNair, Alistair ^a   Gane, Edward ^a   Portmann, Bernard ^a   Pagliuca, Anthony ^a   Rela, Mohamed ^a   Heaton, Nigel ^a   Mufti, Ghulam J ^a   Williams, Roger ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; EB virus; Liver transplantation; Lymphoproliferative disorder

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; BLEOMYCIN; CD20 ANTIGEN; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0030729889     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80145-6     Document Type: Article

References (28)

1. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc. 1:1969;106-112.
2. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc. 23:1991;1101-1103.
3. Reyes J, Tzakis A, Green M, Nour B, Nalesnik M, Van Thiel D, et al. Posttransplant lymphoproliferative disorders occurring under primary FK506 immunosuppression. Transplant Proc. 23:1991;3044-3046.
4. Starzl T, Porter K, Iwatsuki S, Rosenthal J, Nalesnik MA, Ho M, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. i:1984;584-587.
5. Niedobitek G, Young L. Epstein-Barr virus persistence and virus-associated tumours. Lancet. 343:1994;333-335.
6. Rooney C, Smith C, Ng C, Loftin S, Li C, Krance RA, et al. Use of gene-modified virus-specific T-lymphocytes to control Epstein-Barr virus related lymphoproliferation. Lancet. 345:1995;9-13.
7. Fischer A, Blanche S, Le Bidois J, Bordigoni P, Garnier J, Niaudet P, et al. Anti-B cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med. 324:1991;1451-1456.
8. Shapiro R, Chauvenet A, McGuire W, Pearson A, McGlave P, et al. Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gammaglobulin. [letter] N Engl J Med. 318:1988;1334.
9. Baiocchi P, Caligiuri A. Low dose IL2 prevents the development of Epstein Barr virus associated lymphoproliferative disorder in the SCID-human mouse. [abstract] Blood. 82:1993;385. (Suppl).
10. Garrett TJ, Chadburn A, Barr ML, Drusin RE, Chen JM, Schulman LL, et al. Posttransplant lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. Cancer. 72:1993;2782-2785.
11. Swinnen L, Costanzo-Nordin M, Fisher R. Promace-Cytabom induces durable complete remissions (CR) in post cardiac transplant lymphoma (PTL). Proc Am Soc Clin Oncol. 11:1992;318.
12. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley R, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 41:1981;4262-4279.
13. Griffais R, Andre P, Thibon M. K-tuple frequency in the human genome and polymerase chain reaction. Nucleic Acid Res. 19:1991;3887-3891.
14. Laroche C, Drouet E, Brousset P, Pain C, Boibieux A, Biron F, et al. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas. J Med Virol. 46:1995;66-74.
15. Cesarman E, Chang Y, Moore P, Said J. Kaposi's sarcoma-associated herpes virus like DNA sequences in AIDS related body cavity lymphomas. N Engl J Med. 332:1995;1186-1191.
16. Cleary M, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac transplant recipients: clonal analysis based on immunoglobulin gene rearrangements. N Engl J Med. 310:1984;477-482.
17. Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: the dualistic effect. Hepatology. 17:1993;1008-1015.
18. Randhawa P, Yousem S, Paradis I, Dauber J, Griffith B, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol. 92:1989;177-185.
19. Penn I. Cancers complicating organ transplantation. N Engl J Med. 323:1990;1767-1769.
20. Lebland V, Sutton L, Dorent R, Davi F, Bitker M, Gabarre J, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol. 13:1995;961-968.
21. Hanto D, Frizzera G, Gajl-Peczalska K, Balfour H Jr, Simmons RL, Najarian JS. Acyclovir therapy of Epstein Barr virus-induced post transplant lymphoproliferative diseases. Transplant Proc. 17:1985;89.
22. Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, d'Alessandro AM, Kalayoglu M, et al. Treatment of severe Epstein Barr virus-induced lymphoproliferative syndrome with Gancyclovir; two cases after solid organ transplantation. Am J Med. 86:1989;241.
23. Fisher R, Gaynor E, Dahlberg S, Oken M, Grogan T, Mize E, et al. Comparison of a standard regimen (CHOP) with three infusive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 328:1993;1002-1006.
24. Bird G, Smith H, Portmann B, Alexander G, Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med. 270:1989;895-902.
25. Galbraith R, Williams R, Eddleston A, Zuckerman A, Bagshawe K. Fulminant hepatic failure in leukaemia and chorio-carcinoma related to withdrawal of cytotoxic drug therapy. Lancet. ii:1975;528-530.
26. Papadopoulos EB, Ladanyi M, Emanuel E, Mackinnon S, Boulad F, Carabasi MH, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med. 330:1994;1185-1191.
27. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood. 87:1996;2594-2603.
28. Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol. 89:1995;89-103.